Patents by Inventor Frederik Giesel

Frederik Giesel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FAP INHIBITOR
    Publication number: 20230112012
    Abstract: The present invention relates to a compound of formula (I), a pharmaceutical composition comprising or consisting of said compound, a kit comprising or consisting of said compound or pharmaceutical composition and use of the compound or pharmaceutical composition in the diagnosis or treatment of a disease characterized by overexpression of fibroblast activation protein (FAP).
    Type: Application
    Filed: July 1, 2022
    Publication date: April 13, 2023
    Inventors: Uwe HABERKORN, Anastasia LOKTEV, Thomas LINDNER, Walter MIER, Frederik GIESEL, Clemens KRATOCHWIL
  • Treatment of PMSA expressing cancers
    Patent number: 10980901
    Abstract: The invention relates to a method for treating PSMA expressing cancers, wherein the method comprises administering to patient in need thereof an effective amount of one or more Ac-225-radiopharmaceuticals, wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a dosage of from 25 kBq to 400 kBq/kg of body weight of said patient or wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a unitary dosage of from 3 MBq to 30 MBq to said patient.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: April 20, 2021
    Assignees: The European Atomic Energy Community (EURATOM), Represented by the European Commission, Universität Heidelberg
    Inventors: Alfred Morgenstern, Frank Bruchertseifer, Christos Apostolidis, Uwe Haberkorn, Frederik Giesel, Clemens Kratochwil
  • FAP INHIBITOR
    Publication number: 20210038749
    Abstract: The present invention relates to a compound of formula (I), a pharmaceutical composition comprising or consisting of said compound, a kit comprising or consisting of said compound or pharmaceutical composition and use of the compound or pharmaceutical composition in the diagnosis or treatment of a disease characterized by overexpression of fibroblast activation protein (FAP).
    Type: Application
    Filed: February 6, 2019
    Publication date: February 11, 2021
    Inventors: Uwe HABERKORN, Anastasia LOKTEV, Thomas LINDNER, Walter MIER, Frederik GIESEL, Clemens KRATOCHWIL
  • TREATMENT OF PMSA EXPRESSING CANCERS
    Publication number: 20200016281
    Abstract: The invention relates to a method for treating PSMA expressing cancers, wherein the method comprises administering to patient in need thereof an effective amount of one or more Ac-225-radiopharmaceuticals, wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a dosage of from 25 kBq to 400 kBq/kg of body weight of said patient or wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a unitary dosage of from 3 MBq to 30 MBq to said patient.
    Type: Application
    Filed: December 15, 2016
    Publication date: January 16, 2020
    Inventors: Alfred MORGENSTERN, Frank BRUCHERTSEIFER, Christos APOSTOLIDIS, Uwe HABERKORN, Frederik GIESEL, Clemens KRATOCHWIL
  • Method to derive anatomical and/or pathological structures from data of imaging technologies
    Patent number: 8369925
    Abstract: A method to derive anatomical structures from non-invasive imaging technologies is provided. Non-invasive imaging technologies are computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), surface scans and others. Imaging data obtained by a non-invasive technology is used to create a surface contour. The imaging data is transmitted to a rapid prototyping apparatus as readable data. With this readable data the rapid prototyping apparatus establishes a positive or negative surface model, such as a fixation device, a mask, or a prosthesis, or other instruments for medical purposes.
    Type: Grant
    Filed: October 13, 2010
    Date of Patent: February 5, 2013
    Assignees: DKFZ Deutsches Krebforschungszentrum Stiftung des oeffentlichen Rechts, Ruprecht-Karls-Universitaet Heidelberg
    Inventors: Frederik Giesel, Christian Zechmann, Hendrik Von Tengg-Kobligk, Marc Muenter, Juergen Debus, Rainer Neumann, Ulrike Ute Neumann née Pitsch
  • METHOD TO DERIVE ANATOMICAL AND/OR PATHOLOGICAL STRUCTURES FROM DATA OF IMAGING TECHNOLOGIES
    Publication number: 20110118527
    Abstract: A method to derive anatomical and/or pathological structures from non-invasive imaging technologies is provided. Non-invasive imaging technologies are computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), surface scans and others. Imaging data obtained by non-invasive technology is used to create a surface contour. The imaging data is transmitted to rapid prototyping apparatus readable data. At hand of this readable data the rapid prototyping apparatus establishes a positive or negative surface model, such as a fixation device, a mask or a prosthesis or other instruments for medical purposes.
    Type: Application
    Filed: October 13, 2010
    Publication date: May 19, 2011
    Inventors: Frederik Giesel, Christian Zechmann, Hendrik Von Tengg-Kobligk, Marc Muenter, Juergen Debus, Rainer Neumann, Ulrike Ute Neumann née Pitsch
  • Colon contrast enhanced imaging
    Publication number: 20030113267
    Abstract: This invention relates to the use of particular contrast agents to prepare diagostic compounds suitable for non-invasive visualisation under physiological conditions of the intestinal tract, and the colon in particular.
    Type: Application
    Filed: May 1, 2000
    Publication date: June 19, 2003
    Inventors: Michael V. Knopp, Frederik Giesel, Hendrik Von Tengg-Kobligk, Jannis Radeleff